ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 4623

$680K Total Retail Price of All Prescriptions

Rank: 389 out of 4623

896 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 896 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,247 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 980 708 S3 1 3
FUROSEMIDE 973 898 2 8
LISINOPRIL 687 620 3 4
METOPROLOL TARTRATE 683 574 4 9
LOVASTATIN 662 607 5 34
SIMVASTATIN 633 552 6 2
LEVOTHYROXINE SODIUM 624 578 7 1
AMLODIPINE BESYLATE 611 528 8 5
BENAZEPRIL HCL 593 552 9 70
POTASSIUM CHLORIDE 591 558 10 14
ATENOLOL 546 528 11 28
METFORMIN HCL 454 392 12 6
WARFARIN SODIUM 385 334 13 24
OMEPRAZOLE 365 314 14 7
GLIPIZIDE 351 332 15 49
FLUTICASONE PROPIONATE 286 249 16 32
GABAPENTIN 258 210 17 16
ALLOPURINOL 255 253 18 37
ZOLPIDEM TARTRATE 226 196 19 18
NAPROXEN 224 210 20 63
ALENDRONATE SODIUM 217 201 21 22
HYDROCHLOROTHIAZIDE 216 185 22 10
TAMSULOSIN HCL 201 185 23 29
PROAIR HFA 181 153 24 64
DOXAZOSIN MESYLATE 180 176 25 98
AZITHROMYCIN 166 148 26 33
CARVEDILOL 163 140 27 25
VERAPAMIL ER 160 160 28 96
NEXIUM 155 116 29 17
FLUOXETINE HCL 148 95 30 61
PREDNISONE 148 134 30 50
FENOFIBRATE 145 130 32 54
PANTOPRAZOLE SODIUM 144 139 33 35
CYCLOBENZAPRINE HCL 141 90 R 34 53
METOPROLOL SUCCINATE 138 125 35 13
LOSARTAN POTASSIUM 136 127 36 21
ISOSORBIDE MONONITRATE ER 132 119 37 60
DONEPEZIL HCL 129 129 38 30
CIPROFLOXACIN HCL 128 107 39 43
CLOPIDOGREL 127 114 40 31
ATORVASTATIN CALCIUM 122 104 41 12
PRAVASTATIN SODIUM 120 118 42 11
FELODIPINE ER 119 117 43 174
NIFEDIPINE ER 117 105 44 97
FAMOTIDINE 112 95 45 82
TRAMADOL HCL 112 83 45 15
CITALOPRAM HBR 104 89 47 23
AMITRIPTYLINE HCL 102 89 R 48 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 79 49 19
HYDRALAZINE HCL 96 92 50 99
ACETAMINOPHEN-CODEINE 92 92 S3 51 144
CEPHALEXIN 91 78 52 84
CAPTOPRIL 90 85 53 215
RANITIDINE HCL 90 89 53 47
LANTUS 88 42 55 44
NIFEDIAC CC 84 84 56 309
PLAVIX 83 74 57 45
KLOR-CON 8 83 74 57 246
METHOCARBAMOL 82 53 R 59 155
TRIAMTERENE-HCTZ 82 69 59 80
CELEBREX 78 76 61 89
MECLIZINE HCL 77 68 62 125
SPIRONOLACTONE 70 60 63 77
OXYBUTYNIN CHLORIDE 69 57 64 120
CLONIDINE HCL 68 44 65 40
CLOTRIMAZOLE-BETAMETHASONE 65 54 66 147
TRICOR 64 64 67 88
ZETIA 61 61 68 92
QUETIAPINE FUMARATE 60 43 69 74
ADVAIR DISKUS 60 41 69 62
HUMULIN 70-30 60 60 69 202
ACTOS 58 46 72 87
INSULIN SYRINGE 57 44 73 85
DIGOXIN 55 44 74 58
LYRICA 55 22 74 66
KLOR-CON 10 55 51 74 187
GLYBURIDE 55 36 R 74 59
TRAZODONE HCL 54 17 78 42
PHENYTOIN SODIUM EXTENDED 53 33 79 119
ACTONEL 53 49 79 165
CARISOPRODOL 50 15 R 81 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.